Uncovering the role of oncogenic HER2 variants as drivers of pancreatic cancer.

被引：0
|
作者：
Kanu, Elishama
Sills, Joelle
Shelley, Rebecca
Ginzel, Joshua
Fernandes, Joseph
Agritelley, Ethan
Fletcher, Ash
Borowsky, Alexander D.
Shi, Chanjuan
Cardiff, Robert D.
Nussbaum, Daniel
Allen, Peter J.
Snyder, Joshua
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Duke Univ, Sch Med, Durham, NC USA
[3] Univ Calif Davis, Davis, CA USA
[4] Duke Univ, Med Ctr, Dept Surg, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 4_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.4_suppl.772
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：772 / 772
页数：1
相关论文
共 50 条
  • [1] HER2 aberrations and other oncogenic drivers
    不详
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2024, 17 : S66 - S70
  • [2] Novel Alternative Splice Variants of HER2 in Invasive Breast Cancer.
    Assam, E. E.
    Rhodes, A.
    Ladomery, M.
    Harries, L.
    Sohail, M.
    CANCER RESEARCH, 2011, 71
  • [3] Lineage tracing oncogenic isoforms of HER2 in a mouse model of pancreatic cancer
    Kanu, Elishama N.
    Sills, Joelle
    Shelley, Rebecca
    Ginzel, Joshua D.
    Fernandes, Joseph
    Fletcher, Ashley A.
    Allen, Peter J.
    Nussbaum, Daniel P.
    Snyder, Joshua C.
    CANCER RESEARCH, 2024, 84 (02)
  • [4] The role of serum HER2 as an alternative to fluorescence in situ hybridization for HER2 in metastatic breast cancer.
    Kong, SY
    Kwon, Y
    Lee, DH
    Lee, JS
    Lee, ES
    Ro, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 48S - 48S
  • [5] Oncogenic HER2 fusions in gastric cancer
    De-Hua Yu
    Lili Tang
    Hua Dong
    Zhengwei Dong
    Lianhai Zhang
    Jiangang Fu
    Xinying Su
    Tianwei Zhang
    Haihua Fu
    Lu Han
    Liang Xie
    Hao Chen
    Ziliang Qian
    Guanshan Zhu
    Jia Wang
    Qingqing Ye
    Jingchuan Zhang
    Xiaolu Yin
    Xiaolin Zhang
    Jiafu Ji
    Qunsheng Ji
    Journal of Translational Medicine, 13
  • [6] Oncogenic HER2 fusions in gastric cancer
    Yu, De-Hua
    Tang, Lili
    Dong, Hua
    Dong, Zhengwei
    Zhang, Lianhai
    Fu, Jiangang
    Su, Xinying
    Zhang, Tianwei
    Fu, Haihua
    Han, Lu
    Xie, Liang
    Chen, Hao
    Qian, Ziliang
    Zhu, Guanshan
    Wang, Jia
    Ye, Qingqing
    Zhang, Jingchuan
    Yin, Xiaolu
    Zhang, Xiaolin
    Ji, Jiafu
    Ji, Qunsheng
    JOURNAL OF TRANSLATIONAL MEDICINE, 2015, 13
  • [7] Prognostic role of plasma HER2 gene copy number in patients with HER2 positive metastatic breast cancer.
    Ran, Ran
    Huang, Wenfa
    Lin, Shao
    Niu, Yunyun
    Rugo, Hope S.
    Kong, Weiyao
    Bo, Shiping
    Lu, Sijia
    Li, Huiping
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] HER2 overexpressing metastatic breast cancer.
    Spigel D.R.
    Burstein H.J.
    Current Treatment Options in Oncology, 2002, 3 (2) : 163 - 174
  • [9] Disparities in HER2 testing in breast cancer.
    Paryani, Vijay
    Schroeder, Mary Chen
    Klepin, Heidi D.
    Melin, Susan Anitra
    Russell, Greg B.
    Winkfield, Karen Marie
    Thomas, Alexandra
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] EGFR and HER2 inhibition in pancreatic cancer
    Naomi Walsh
    Susan Kennedy
    AnneMarie Larkin
    Brendan Corkery
    Lorraine O’Driscoll
    Martin Clynes
    John Crown
    Norma O’Donovan
    Investigational New Drugs, 2013, 31 : 558 - 566
12345